MAIA · MAIA Biotechnology, Inc. · Metrics
Market Cap
$65.08M
Shares
60.83M
Volume · Oct 20
168.99K
Avg daily vol (3M)
482.28K
MAIA metrics
58 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$1.12
Market cap
$65.08M
Price action
20 metricsPrice change (1W)
-9.3%
Price change (30D)
-19.5%
Price change (3M)
-16.4%
Price change (6M)
-24.1%
Price change (YTD)
-30.1%
Price change (1Y)
-16.4%
Trailing year
Price change (5Y)
—
52-week high
$2.95
52-week low
$0.87
Change from 52-week high
-63.7%
Change from 52-week low
+22.8%
Annualized volatility
87.1%
Annualized volatility (3M)
46.9%
Beta
1.6
RSI (14D)
32.3
Price vs SMA 50
-17.0%
Price vs SMA 200
-27.7%
Avg volume (3M)
487,470
Relative volume
1.6
Average dollar volume
$627,722
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
60.83M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
3.2
reciprocal yield 30.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-40.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$28.95M
Net income (TTM)
−$26.85M
Trailing 12 months
Diluted EPS (TTM)
$-0.63
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+100.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-129.8%
Return on assets
-95.1%
Debt / equity
0.0
Current ratio
4.5
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
4.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$0
Latest balance sheet
Cash & equivalents
$0
Total assets
$28.24M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$22.57M
Capital expenditures (TTM)
—
R&D (TTM)
−$171,343
SG&A (TTM)
—
Stock compensation (TTM)
$2.83M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
36
13F filer change QoQ
+3
Institutional ownership
22.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
13.5%
Private-fund adviser ownership
13.5%
Active holders' share change QoQ
-7.4%
Holder tenure
3.7
Price vs estimated holder cost
-20.3%
Ownership (registered funds)
1 metricsIndex-fund ownership
4.7%
Short interest
3 metricsShort interest
4.4%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
64 / 100
Insider activity
2 metricsNet insider buying (90D)
$352,317
Insider-sentiment score
91 / 100
Risk flags
1 metricsGoing concern
—